Document Type
Article
Publication Date
2018
ISSN
1748-720X
Publisher
American Society of Law, Medicine & Ethics
Language
en-US
Abstract
The need for new “pull” incentives to stimulate antibiotic R&D is widely recognized. Due to the global diversity of health systems, combined with different challenges faced by antibiotics used in different types of healthcare settings, there is no one-size-fits-all solution. Instead, different “pull” incentives should be tailored to local contexts, priorities, and antibiotic types. Policymakers and industry should collaborate to identify appropriate solutions at the local, regional, and global levels.
Recommended Citation
Kevin Outterson,
A Perspective on Incentives for Novel Inpatient Antibiotics: No One-Size-Fits-All
,
in
46
Journal of Law, Medicine & Ethics
59
(2018).
Available at:
https://scholarship.law.bu.edu/faculty_scholarship/1762
